Evidence map›Paper›PMID 42506769›Full record

ArticleTropical medicine and infectious disease2026

Acceptability of Integrated Vector Management of

Neal Alexander, Nurulhusna Ab Hamid, Farah Diana Ariffin, Muriel Rabilloud, Tim W R Möhlmann, Frédéric Schmitt, Jason H Richardson, Mitra Saadatian-Elahi

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Neal AlexanderInternational Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.ORCID 0000-0002-6707-7876
Nurulhusna Ab HamidMedical Entomology Unit, Institute for Medical Research, National Institutes of Health, Ministry of Health, Setia Alam 40170, Selangor, Malaysia.ORCID 0000-0003-0135-9720
Farah Diana AriffinMedical Entomology Unit, Institute for Medical Research, National Institutes of Health, Ministry of Health, Setia Alam 40170, Selangor, Malaysia.ORCID 0009-0007-1328-2827
Muriel RabilloudLaboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, UMR 5558, F-69100 Villeurbanne, France.ORCID 0000-0003-1324-0356
Tim W R MöhlmannIn2Care B.V., Marijkeweg 22, 6709 PG Wageningen, The Netherlands.
Frédéric SchmittEnvu, 1 Place Giovanni Da Verrazzano, F-69009 Lyon, France.
Jason H RichardsonInnovative Vector Control Consortium, Pembroke Place, Liverpool L3 5QA, UK.
Mitra Saadatian-ElahiCentre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, CEDEX 07, F-69364 Lyon, France.ORCID 0000-0003-1265-8806

Funding

Australian GovernmentEnvuFondation Innovations en InfectiologieForeign, Commonwealth & Development OfficeMinistry of Health
6 · The paper itself

Abstract

For dengue, there is little evidence regarding community-level acceptance, facilitators and barriers for integrated vector management (IVM). We carried out a survey to measure these aspects in the context of a large cluster-randomized controlled trial of IVM against dengue vectors in urban Malaysia, in which the component control methods were (i) outdoor residual spraying, (ii) autodissemination devices (ADDs) and (iii) community engagement. The survey population comprised (i) members of the Joint Management Body (JMB) of building developments in both arms, and (ii) residents in the intervention arm. Members of both groups were requested to complete a structured questionnaire, through face-to-face interviews. Among JMB responders, 138 were the intervention clusters, and 94 from those receiving routine activities (control arm), and there were 604 responders among residents of intervention clusters. Among the JMB members, safety of the control methods (spraying and ADDs) was among the most important potential facilitators. Among barriers, the ones identified by over one-third of the participants were lack of information about the iDEM IVM methods, lack of communication and of involvement with the iDEM project personnel. Overall, the iDEM IVM methods were seen positively, and investment by the trial in community engagement may have contributed to this.

Indexed as

autodissemination devicesbarrierscluster randomized trialdenguefacilitatorsintegrated vector managementresidual spraying

Identifiers

PMID42506769
PMCPMC13418634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.